Ukar Remedy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth %
- Profit Growth 663.85%
- Ebitda 856.85%
- Net Worth 49.03%
- Total Assets 4392.65%
About Ukar Remedy
Ukar Remedy Private Limited (URPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 May 2017 (Seven years and nine months 22 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rachna Sarin, Ankur Tyagi, and Rahul Sarin serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999DL2017PTC316966
- Company No.
316966
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 2017
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ukar Remedy?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rachna Sarin  | Director | 01-May-2017 | Current |
| Ankur Tyagi | Director | 01-May-2017 | Current |
| Rahul Sarin | Director | 01-May-2017 | Current |
Financial Performance of Ukar Remedy.
Ukar Remedy Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 663.85% increase in profit. The company's net worth Soared by an impressive increase of 49.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ukar Remedy?
In 2019, Ukar Remedy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ukar Healthcare Private LimitedRachna Sarin and Rahul Sarin are mutual person
Eshar Healthcare Private LimitedAnkur Tyagi is a mutual person
- Umar Medicare Private Limited
Ankur Tyagi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ukar Remedy?
Unlock and access historical data on people associated with Ukar Remedy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ukar Remedy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ukar Remedy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.